Skip to main content
logo
Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
22.00
0.00 (0.00%)
At close: Apr 20, 2026, 4:00 PM EDT
22.69
+0.69 (3.14%)
After-hours: Apr 20, 2026, 4:34 PM EDT

Alamar Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Revenue
74.2125.14
Revenue Growth (YoY)
195.17%-
Cost of Revenue
32.5116.54
Gross Profit
41.718.61
Selling, General & Admin
35.5718.94
Research & Development
37.4739.23
Operating Expenses
73.0458.18
Operating Income
-31.33-49.57
Interest Expense
-0.4-2.08
Interest & Investment Income
2.164.68
Other Non Operating Income (Expenses)
0.42-0.09
Pretax Income
-29.15-47.06
Income Tax Expense
0.670.01
Net Income
-29.82-47.07
Preferred Dividends & Other Adjustments
--0.8
Net Income to Common
-29.82-46.27
Shares Outstanding (Basic)
2825
Shares Outstanding (Diluted)
2829
Shares Change (YoY)
-2.89%-
EPS (Basic)
-1.07-1.82
EPS (Diluted)
-1.07-1.90
Free Cash Flow
-58.98-58.16
Free Cash Flow Per Share
-2.11-2.02
Gross Margin
56.20%34.23%
Operating Margin
-42.22%-197.15%
Profit Margin
-40.18%-184.03%
Free Cash Flow Margin
-79.48%-231.33%
EBITDA
-28.57-47.27
EBITDA Margin
-38.50%-188.03%
D&A For EBITDA
2.762.29
EBIT
-31.33-49.57
EBIT Margin
-42.22%-197.15%
Revenue as Reported
74.2125.14
Advertising Expenses
1.50.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q